Robert Uzzo MD MBA
Minimally Invasive Surgery, Surgical Oncology
Chair, Surgical Oncology; G. Willing "Wing" Pepper Chair in Cancer Research; Senior Vice-President, Physician Services; President, FCCC Medical Group, Inc.; Professor of Surgery, Temple University Health System
Join to View Full Profile
333 Cottman AvenueSuite C302Philadelphia, PA 19111
Phone+1 215-728-3096
Fax+1 215-214-1734
Dr. Uzzo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- https://www.foxchase.org/robert-uzzo
Education & Training
Cleveland Clinic FoundationFellowship, Minimally Invasive Urologic Surgery, 1997 - 2000
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1993 - 1997- New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1993 - 1996
- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1991 - 1993
Weill Cornell MedicineClass of 1991
Certifications & Licensure
NJ State Medical License 2021 - 2027
PA State Medical License 2000 - 2026
OH State Medical License 1997 - 2003
NY State Medical License 1993 - 1998
American Board of Urology Urology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Philadelphia Magazine Castle Connolly, 2005-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer Start of enrollment: 2002 Dec 01
- Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery Start of enrollment: 2006 Apr 24
Publications & Presentations
PubMed
- Robotic partial nephrectomy to treat large (T2) cystic renal cell carcinoma: a multi-institutional analysis (ROSULA Collaborative Group).Lin Zhao, Xiaolei Shi, Fei Guo, Jiaying Miao, Chao Zhi
International Urology and Nephrology. 2026-01-01 - Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobank.Laura Bukavina, Ilaha Isali, Sneha Parekh, Sarah Psutka, Nicole Uzzo
Bladder Cancer. 2025-09-17 - 2 citationsHigh Rate of Return to Sport for Athletes Undergoing Articular Cartilage Restoration Procedures for the Knee: A Systematic Review of Contemporary Studies.Kyle N Kunze, Michael Mazzucco, Zach Thomas, Robert Uzzo, Scott A Rodeo
The American Journal of Sports Medicine. 2025-08-01
Journal Articles
- Assessment of Volume Preservation Performed Before or After Partial Nephrectomy Accurately Predicts Postoperative Renal Function: Results from a Prospective Multicente...Alexander Kutikov, Robert G Uzzo, Brian R Lane, Urologic Oncology
- Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesRichard E Greenberg, Rosalia Viterbo, Timothy Ito, Marc C Smaldone, Joseph R Testa, Philip H Abbosh, Robert G Uzzo, Alexander Kutikov, The Journal of Urology
- Addressing the evidence gap—randomized controlled trials for the surgical management of localized genitourinary tract malignanciesSmaldone MC, Kutikov A, Uzzo RG, Corcoran AT, Urol Oncol, 1/1/2013
Press Mentions
Uromodulin Protects Against Upper Urinary Tract InfectionsMarch 27th, 2025- Temple Health Launches New Fox Chase-Temple Urologic InstituteApril 27th, 2023
- HUP and Fox Chase Lead the Region in Cancer Surgery Volume, New Report FindsApril 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
